Jeffrey Settleman
Impact in
- Oncology top 0.05%
- HER2/EGFR in Cancer Research
- Colorectal Cancer Treatments and Studies
- Pulmonary and Respiratory Medicine top 0.05%
- Lung Cancer Treatments and Mutations
Papers in
-
- Protein Kinase Regulation and GTPase Signaling 48
- Melanoma and MAPK Pathways 17
- PI3K/AKT/mTOR signaling in cancer 16
- Oncology 52
- HER2/EGFR in Cancer Research 20
- Cancer-related Molecular Pathways 12
- Co-authors
- Daniel A. Haber (25 shared papers)Daphne W. Bell (8 shared papers)Sreenath V. Sharma (17 shared papers)Raffaella Sordella (11 shared papers)Jeffrey A. Engelman (16 shared papers)A. John Iafrate (9 shared papers)Thomas J. Lynch (9 shared papers)Ultan McDermott (10 shared papers)
- Journals
- Cancer Research (15 papers)Molecular and Cellular Biology (8 papers)Cell (7 papers)Journal of Biological Chemistry (7 papers)Current Biology (6 papers)
- Partner nations
- United StatesHungaryUnited Kingdom
In The Last Decade
Jeffrey Settleman
159 papers receiving 23.2k citations
Jeffrey Settleman's Hit Papers
Peers
Comparison fields: 5 of 145
- Oncology 8.6k
- Pulmonary and Respiratory Medicine 6.9k
- Cancer Research 3.2k
- Cell Biology 3.6k
- Molecular Biology 13.1k
Countries citing papers authored by Jeffrey Settleman
This map shows the geographic impact of Jeffrey Settleman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey Settleman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey Settleman more than expected).
Fields of papers citing papers by Jeffrey Settleman
This network shows the impact of papers produced by Jeffrey Settleman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey Settleman. The network helps show where Jeffrey Settleman may publish in the future.
Co-authors
The 25 scholars most cited alongside Jeffrey Settleman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 159 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Epidermal growth factor receptor mutations in lung cancer Hit paper breakdown → | 2007 | 2492 |
| 2 | Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Who Harbor EML4-ALK Hit paper breakdown → | 2009 | 1469 |
| 3 | Gefitinib-Sensitizing EGFR Mutations in Lung Cancer Activate Anti-Apoptotic Pathways Hit paper breakdown → | 2004 | 1346 |
| 4 | Detection of Mutations in EGFR in Circulating Lung-Cancer Cells Hit paper breakdown → | 2008 | 1300 |
| 5 | Irreversible inhibitors of the EGF receptor may circumvent acquired resistance to gefitinib Hit paper breakdown → | 2005 | 778 |
| 6 | EGFR-Mediated Reactivation of MAPK Signaling Contributes to Insensitivity of BRAF -Mutant Colorectal Cancers to RAF Inhibition with Vemurafenib Hit paper breakdown → | 2012 | 774 |
| 7 | Normal and oncogenic p21ras proteins bind to the amino-terminal regulatory domain of c-Raf-1 Hit paper breakdown → | 1993 | 763 |
| 8 | First-Line Gefitinib in Patients With Advanced Non–Small-Cell Lung Cancer Harboring SomaticEGFRMutations Hit paper breakdown → | 2008 | 663 |
| 9 | SCFFBW7 regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction Hit paper breakdown → | 2011 | 541 |
| 10 | 2008 | 464 | |
| 11 | 2008 | 407 | |
| 12 | 2006 | 401 | |
| 13 | 2011 | 339 | |
| 14 | 2006 | 333 | |
| 15 | 2003 | 324 | |
| 16 | 1997 | 322 | |
| 17 | 2008 | 319 | |
| 18 | 2008 | 313 | |
| 19 | 1992 | 313 | |
| 20 | 2007 | 310 |
About Jeffrey Settleman
Jeffrey Settleman is a scholar working on Molecular Biology, Oncology, Cell Biology, Pulmonary and Respiratory Medicine and Immunology and Allergy, having authored 159 papers that have together received 23.7k indexed citations. Recurring topics across this work include Protein Kinase Regulation and GTPase Signaling (48 papers), Lung Cancer Treatments and Mutations (30 papers), Cellular Mechanics and Interactions (24 papers), HER2/EGFR in Cancer Research (20 papers), Cell Adhesion Molecules Research (19 papers), Melanoma and MAPK Pathways (17 papers), PI3K/AKT/mTOR signaling in cancer (16 papers) and Cancer-related Molecular Pathways (12 papers). The work is most often cited by research in Oncology (8.6k citations), Pulmonary and Respiratory Medicine (6.9k citations), Cancer Research (3.2k citations), Cell Biology (3.6k citations) and Molecular Biology (13.1k citations). Jeffrey Settleman has collaborated with scholars based in United States, Hungary and United Kingdom. Frequent co-authors include Daniel A. Haber, Daphne W. Bell, Sreenath V. Sharma, Raffaella Sordella, Jeffrey A. Engelman, A. John Iafrate, Thomas J. Lynch, Ultan McDermott, Margaret P. Quinlan and Ryan B. Corcoran. Their work appears in journals such as Cancer Research, Molecular and Cellular Biology, Cell, Journal of Biological Chemistry and Current Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.